IMS Health Holdings, Inc. IMS
31.34 0.00 (+0.00%)
At closeJun 28, 2019, 6:07 PM EDT
30.37 Day range 31.34
22.36 52-week range 31.59
- Volume
- 4.03M
- Avg volume
- 1.26M
- Open
- 30.50
- Previous close
- 31.34
- Day's range
- 30.37 – 31.34
- 52-week range
- 22.36 – 31.59
- Earnings date
- Nov 3, 2016
No chart data for this range yet.
Next earnings
Nov 3, 2016
Expected Nov 3, 2016. Consensus EPS estimate 0.36.
Financials — quick view
IMS Revenue — quarterly 802.00M
IMS Net income — quarterly 24.00M
IMS EPS — quarterly 0.07
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 3, 2016 | Sep 1, 2016 | 0.36 | — | — | — |
| Jul 27, 2016 | Jun 1, 2016 | 0.38 | — | — | — |
| May 3, 2016 | Mar 1, 2016 | 0.38 | — | — | — |
| Feb 3, 2016 | Dec 1, 2015 | 0.32 | — | — | — |
| Oct 29, 2015 | Sep 1, 2015 | 0.33 | — | — | — |
| Jul 31, 2015 | Jun 1, 2015 | 0.30 | — | — | — |
News
C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting 
AbbVie to Present Phase 3 Etentamig Results and Data from Broad Multiple Myeloma Portfolio at the 2026 International Myeloma Society (IMS) Meeting 
C4 Therapeutics to Present New Biomarker Data on the Immunomodulatory Effects of Cemsidomide in Combination with Dexamethasone from its Phase 1 Relapsed/Refractory Multiple Myeloma Trial at the 23rd International Myeloma Society (IMS) Annual Meeting 
MACOM and Elve to Demonstrate a V-Band Linearized TWTA for Satellite Communications and Defense Applications at IMS 2026 
Guerrilla RF Announces Expanded Focus on Tactical Radio Market, Debuts New Solutions Guide at IMS2026 
MACOM IMS 2026 Product Announcements for Satellite Communications 
MACOM IMS 2026 Product Announcements for Aerospace and Defense 
Aramark Sports + Entertainment Drives New Food & Beverage and Premium Hospitality Experiences at Indianapolis Motor Speedway for 2026 
IMS Announces Executive AEO Training to Help Companies Increase Visibility Across Generative AI Platforms Including ChatGPT, Claude, Grok, and Perplexity 
Charles River Wealth to Expand Capabilities Supporting Private Assets within Unified Managed Accounts (UMA)
Your note
Sign in to keep a note on IMS — it syncs with the Stock Master app.